US Stock MarketDetailed Quotes

RGNX Regenxbio

Watchlist
  • 6.720
  • +0.170+2.60%
Close Mar 14 16:00 ET
  • 6.720
  • 0.0000.00%
Post 19:12 ET
336.58MMarket Cap-1.46P/E (TTM)

About Regenxbio Company

REGENXBIO, Inc. is a clinical-stage biotechnology company, which engages in the development, commercialization, and licensing of recombinant adeno-associated virus gene therapy. Its product candidates include the NAV Technology Platform, which consists of exclusive rights to novel adeno-associated viral vectors, and therapeutic programs such as RGX-314, RGX-202, RGX-121, RGX-111, RGX-181, and RGX-381. The company was founded by Kenneth T. Mills and James M. Wilson on July 16, 2008 and is headquartered in Rockville, MD.

Company Profile

SymbolRGNX
Company NameRegenxbio
Listing DateSep 17, 2015
Issue Price22.00
Founded2008
CEOMr. Curran Simpson
MarketNASDAQ
Employees344
Fiscal Year Ends12-31
Address9804 Medical Center Drive
CityRockville
ProvinceMaryland
CountryUnited States of America
Zip Code20850
Phone1-240-552-8181

Company Executives

  • Name
  • Position
  • Salary
  • Curran Simpson
  • Director, President and Chief Executive Officer
  • 2.95M
  • Mitchell Chan
  • Executive Vice President, Chief Financial Officer and Principal Accounting Officer
  • --
  • Stephen Pakola, M.D.
  • Executive Vice President and Chief Medical Officer
  • 3.31M
  • Patrick J. Christmas
  • Executive Vice President and Chief Legal Officer
  • --
  • Dr. Olivier Danos, PhD
  • Executive Vice President and Chief Scientific Officer
  • 2.99M
  • Kenneth T. Mills
  • Chairman of the Board
  • 5.92M
  • Allan M. Fox
  • Director
  • 354.98K
  • Dr. David C. Stump,M.D.
  • Independent Director
  • 339.98K
  • Dr. Alexandra Glucksmann, PhD
  • Independent Director
  • 327.48K
  • Jennifer Zachary
  • Independent Director
  • 329.98K
  • George V. Migausky
  • Independent Director
  • 339.98K
  • Daniel Tasse
  • Lead Independent Director
  • 334.98K
  • Dr. Argeris N. Karabelas, PhD
  • Independent Director
  • 352.48K
  • Dr. Jean Bennett, M.D.,Pd.D
  • Independent Director
  • 324.98K

Trending Stocks

U.S. Crypto Concept Stocks U.S. Crypto Concept Stocks

Companies involved in the creation, trade, and services of digital forms of money.Displayed third-party logos, brands, or trademark images on screens or web pages are only for identification purposes and remain the property of their respective owners.Displayed third-party logos, brands, or trademark images on screens or web pages are only for identification purposes and remain the property of their respective owners. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in U.S. Crypto Concept Stocks, ranked from highest to lowest based on real-time market data. Companies involved in the creation, trade, and services of digital forms of money.Displayed third-party logos, brands, or trademark images on screens or web pages are only for identification purposes and remain the property of their respective owners.Displayed third-party logos, brands, or trademark images on screens or web pages are only for identification purposes and remain the property of their respective owners. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in U.S. Crypto Concept Stocks, ranked from highest to lowest based on real-time market data.

Unlock Now
Discussing
Trump 2.0 Era: How will global markets evolve?
🎙️Discussion: 1. How will tariff policies affect the movement of key assets such as U.S. stocks, gold, and Bitcoin? 2. Given this context, Show More
Reassessing Chinese Assets
Following the introduction of China's groundbreaking DeepSeek technology, Wall Street giants have revised their investment outlooks for the Chinese market.